Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Fanchon, Louise M; Dogan, Snjezana; Moreira, Andre L; Carlin, Sean A; Schmidtlein, C Ross; Yorke, Ellen; Apte, Aditya; Burger, Irene A; Durack, Jeremy C; Erinjeri, Joseph P; Maybody, Majid; Schöder, Heiko; Siegelbaum, Robert H; Sofocleous, Constantinos T; Deasy, Joseph O; Solomon, Stephen B; Humm, John L; Kirov, Assen S (2015). Feasibility for in situ, High Resolution Correlation of Tracer Uptake with Histopathology by Quantitative Autoradiography of Biopsy Specimens Obtained under FDG PET/CT Guidance. Journal of Nuclear Medicine, 56(4):538-544.

Vargas, Hebert Alberto; Burger, Irene A; Donati, Olivio F; Andikyan, Vaagn; Lakhman, Yulia; Goldman, Debra A; Schöder, Heiko; Chi, Dennis S; Sala, Evis; Hricak, Hedvig (2013). Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration. International Journal of Gynecological Cancer, 23(8):1512-1519.

Burger, Irene A; Vargas, Hebert Alberto; Goldman, Debra A; Gonen, Mithat; Kumar, Anita; Zelenetz, Andrew D; Schöder, Heiko; Hricak, Hedvig (2013). The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma. European Journal of Nuclear Medicine and Molecular Imaging, 40(5):701-707.

Burger, Irene A; Vargas, Hebert Alberto; Donati, Olivio F; Andikyan, Vaagn; Sala, Evis; Gonen, Mithat; Goldman, Debra A; Chi, Dennis S; Schöder, Heiko; Hricak, Hedvig (2013). The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration. Gynecologic Oncology, 129(3):586-592.

This list was generated on Tue Jul 16 18:53:48 2019 CEST.